AstraZeneca Vaccine 430,000 Doses Arrive on the 3rd... "Domestic Production Imported via Europe"

297,000 Pfizer Doses Supplied in June... Task Force "Arrived Sooner Than Expected"

On the 24th, when the first shipment of the AstraZeneca COVID-19 vaccine was made in Korea, a vaccine transport vehicle that left the SK Bioscience factory in Andong, Gyeongbuk, arrived at the Gtree BNT logistics center in Icheon, Gyeonggi-do.

The vaccines that arrived at the logistics center on this day are part of the 750,000 doses contracted by the government, totaling 150,000 doses, and are scheduled to be sequentially transported to public health centers and nursing hospitals nationwide starting from the 25th, the following day. 2021.2.24 Photo by Joint Press Corps

[Asia Economy Reporter Seo So-jung] The COVID-19 Vaccination Response Promotion Team (Director Jung Eun-kyung) announced on the 1st that 432,000 doses of the COVAX AstraZeneca vaccine are scheduled to arrive at Incheon Airport at 14:55 on the 3rd.

The Promotion Team stated, "Initially, according to COVAX's guidance, the arrival was expected around mid-month, but due to the completion of administrative procedures related to UNICEF and procurement, it will arrive earlier than expected."

The COVAX AstraZeneca vaccine arriving on the 3rd is produced domestically by SK Bioscience (Andong factory). It will be introduced after export to Europe as per COVAX administrative procedures, and upon domestic export, national lot release approval will confirm quality suitability, allowing immediate use for vaccination.

Additionally, 297,000 doses of the COVAX Pfizer vaccine are planned to be supplied by the end of June.

The quantity scheduled to arrive at the end of June is the remaining amount of the 414,000 doses of Pfizer vaccine allocated from COVAX, excluding the 117,000 doses that arrived on February 26th. Specific arrival schedules will be announced later.

Furthermore, 1 million doses of individually contracted Pfizer vaccines were introduced last month, and 6 million doses for the second quarter have been confirmed for sequential weekly introduction: 1 million doses in April, 1.75 million doses in May, and 3.25 million doses in June.

Individually contracted AstraZeneca vaccines will be introduced from May to June with a total of 7 million doses.

The government stated, "Many countries are facing difficulties in securing vaccines amid the global shortage of vaccine supplies," and added, "We will review all possible measures to overcome these challenges and ensure that vaccination implementation proceeds without disruption."

This content was produced with the assistance of AI translation services.